MYMD: MyMD Pharmaceuticals, Inc. Stock

by  •  • Comments Off on MYMD: MyMD Pharmaceuticals, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 6.06
Enterprise Value ($M) 3.93
Book Value ($M) 12.77
Book Value / Share 5.92
Price / Book 0.47
NCAV ($M) 0.73
NCAV / Share 0.34
Price / NCAV 8.33

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 1.17
Current Ratio 1.17

Balance Sheet (mrq) ($M)
Current Assets 5.82
Assets 17.86
Liabilities 5.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.36
Net Income -4.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.98
Cash from Investing 1.85
Cash from Financing 13.07

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Global X Management CO LLC 6.11
02-14 13G/A Iroquois Capital Management, LLC 4.99 -64.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 4,509 3,712 121.47
2024-04-25 7,689 3,918 196.25
2024-04-24 27,104 13,482 201.04
2024-04-23 2,157 3,596 59.98
2024-04-22 13,354 12,571 106.23

(click for more detail)

Similar Companies
MNPR – Monopar Therapeutics Inc. MRKR – Marker Therapeutics, Inc.
MTEM – Molecular Templates, Inc. MYNZ – Mainz Biomed N.V.
NATR – Nature's Sunshine Products, Inc.


Financial data and stock pages provided by
Fintel.io